Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases

le Maki Komiyama, Koji Hasegawa
Foilsithe 2021-09-01

European Society of Cardiology Highlights: Late-breaking Trials – COVID-19

le Maki Komiyama, Koji Hasegawa
Foilsithe 2022-02-01

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

le Maki Komiyama, Koji Hasegawa
Foilsithe 2020-07-01

Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic

le Maki Komiyama, Koji Hasegawa
Foilsithe 2020-04-01

Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness

le Maki Komiyama, Koji Hasegawa
Foilsithe 2020-08-01

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?

le Maki Komiyama, Koji Hasegawa, Akira Matsumori
Foilsithe 2020-05-01

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence

le Koji Hasegawa, Maki Komiyama, Yuko Takahashi
Foilsithe 2019-01-01